Similar articles for PMID: 35347010

Year	Number of Results
2011	2
2012	2
2013	3
2014	4
2015	5
2016	7
2017	10
2018	18
2019	12
2020	18
2021	17
2022	14
2023	6
2024	0

1

Baseline Modified Glasgow Prognostic Score (mGPS) Predicts Radiologic Response and Overall Survival in Metastatic Hormone-sensitive Prostate Cancer Treated With Docetaxel Chemotherapy.

Neuberger M, Skladny J, Goly N, Wessels F, WEIß C, Egen L, Erben P, GROß-Weege M, Grüne B, Hartung F, Herrmann J, Honeck P, Jarczyk J, Kowalewski KF, Mühlbauer J, Nitschke K, Nientiedt M, Walach MT, Waldbillig F, Westhoff N, VON Hardenberg J, Kriegmair M, Worst TS, Nuhn P. Neuberger M, et al. Anticancer Res. 2022 Apr;42(4):1911-1918. doi: 10.21873/anticanres.15668. Anticancer Res. 2022. PMID: 35347010

2

Systemic inflammatory biomarkers as predictive and prognostic factors in men with metastatic castration-refractory prostate cancer treated with docetaxel therapy: a comprehensive analysis in a German real-world cohort.

Neuberger M, Goly N, Skladny J, Milczynski V, Weiß C, Wessels F, Nitschke K, Grüne B, Haney CM, Hartung F, Herrmann J, Jarczyk J, Kowalewski KF, Waldbillig F, Kriegmair MC, Westhoff N, Worst TS, Nuhn P. Neuberger M, et al. J Cancer Res Clin Oncol. 2023 Jul;149(7):3371-3381. doi: 10.1007/s00432-022-04220-w. Epub 2022 Aug 8. J Cancer Res Clin Oncol. 2023. PMID: 35939112 Free PMC article.

3

Development of a prognostic model for survival time prediction in castration-resistant prostate cancer patients.

Stangl-Kremser J, Mari A, Suarez-Ibarrola R, D'Andrea D, Korn SM, Pones M, Kramer G, Karakiewicz P, Enikeev DV, Glybochko PV, Briganti A, Shariat SF. Stangl-Kremser J, et al. Urol Oncol. 2020 Jun;38(6):600.e9-600.e15. doi: 10.1016/j.urolonc.2019.11.005. Epub 2020 Jan 14. Urol Oncol. 2020. PMID: 31953003

4

Glasgow prognostic score as a prognostic factor in metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy.

Linton A, Pond G, Clarke S, Vardy J, Galsky M, Sonpavde G. Linton A, et al. Clin Genitourin Cancer. 2013 Dec;11(4):423-30. doi: 10.1016/j.clgc.2013.04.020. Epub 2013 Jun 28. Clin Genitourin Cancer. 2013. PMID: 23816526 Clinical Trial.

5

Prognostic Value of High-Sensitivity Modified Glasgow Prognostic Score in Castration-Resistant Prostate Cancer Patients Who Received Docetaxel.

Ando K, Sakamoto S, Saito S, Maimaiti M, Imamura Y, Sazuka T, Sato N, Komiya A, Anzai N, Ichikawa T. Ando K, et al. Cancers (Basel). 2021 Feb 12;13(4):773. doi: 10.3390/cancers13040773. Cancers (Basel). 2021. PMID: 33673284 Free PMC article.

6

Staging the Tumor and Staging the Host: Pretreatment Combined Neutrophil Lymphocyte Ratio and Modified Glasgow Prognostic Score Is Associated with Overall Survival in Patients with Esophagogastric Cancers Undergoing Treatment with Curative Intent.

McSorley ST, Lau HYN, McIntosh D, Forshaw MJ, McMillan DC, Crumley AB. McSorley ST, et al. Ann Surg Oncol. 2021 Feb;28(2):722-731. doi: 10.1245/s10434-020-09074-5. Epub 2020 Sep 5. Ann Surg Oncol. 2021. PMID: 32892266 Free PMC article.

7

Impact of baseline serum IL-8 on metastatic hormone-sensitive prostate cancer outcomes in the Phase 3 CHAARTED trial (E3805).

Harshman LC, Wang VX, Hamid AA, Santone G, Drake CG, Carducci MA, DiPaola RS, Fichorova RN, Sweeney CJ. Harshman LC, et al. Prostate. 2020 Dec;80(16):1429-1437. doi: 10.1002/pros.24074. Epub 2020 Sep 19. Prostate. 2020. PMID: 32949185 Free PMC article.

8

Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.

Song A, Eo W, Lee S. Song A, et al. World J Gastroenterol. 2015 Nov 21;21(43):12410-20. doi: 10.3748/wjg.v21.i43.12410. World J Gastroenterol. 2015. PMID: 26604648 Free PMC article.

9

Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer.

Demirelli B, Babacan NA, Ercelep Ö, Öztürk MA, Kaya S, Tanrıkulu E, Khalil S, Hasanov R, Alan Ö, Telli TA, Koca S, Arıbal ME, Kuzan B, Dane F, Yumuk PF. Demirelli B, et al. Nutr Cancer. 2021;73(2):230-238. doi: 10.1080/01635581.2020.1749290. Epub 2020 Apr 9. Nutr Cancer. 2021. PMID: 32270713

10

Lymphocyte to Monocyte Ratio and Modified Glasgow Prognostic Score Predict Prognosis of Lung Adenocarcinoma Without Driver Mutation.

Minami S, Ihara S, Kim SH, Yamamoto S, Komuta K. Minami S, et al. World J Oncol. 2018 Feb;9(1):13-20. doi: 10.14740/wjon1084w. Epub 2018 Mar 8. World J Oncol. 2018. PMID: 29581811 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

98 results

Results by year